Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2001-02, Vol.51 (2), p.151-153
Main Authors: Bunnag, Pongamorn, Puavilai, Gobchai, Chanprasertyotin, Suwannee, Chandraprasert, Sunitaya, Suwanwalaikorn, Sompong, Suthijumroon, Ampha, Benjasuratwong, Yupin, Boonyavaraku, Apasanee, Nitiyanant, Wannee, Sriussadaporn, Sutin, Deerochanawong, Chaichan
Format: Article
Language:English
Subjects:
Adult
Aged
Blood Glucose - metabolism
Blood Pressure
Body Mass Index
C-Peptide - blood
Chromans - therapeutic use
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - physiopathology
Drug Therapy, Combination
Glycated Hemoglobin A - analysis
Humans
Hypoglycemic Agents - therapeutic use
Insulin - blood
Middle Aged
Sulfonylurea Compounds - therapeutic use
Thailand
Thiazoles - therapeutic use
Thiazolidinediones
Time Factors
Troglitazone
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8227
1872-8227
DOI:10.1016/S0168-8227(00)00218-7